Symbols

HELP

Cybin·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About HELP

Cybin Inc.

Deuteration Technology Breaks Through in Mental Health! Cybin Secures FDA Breakthrough Therapy Designation, Approaching Key Milestone in Phase III Trials

Industry

Pharmaceutical

Established Date

10/13/2016

Listing Date

01/05/2026

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

03-31

Website

www.cybin.com

Security Type

Common stock

Office address

100 King Street West, Suite 5600, Toronto, Ontario, Canada M5X 1C9

Business

Introduction

Cybin Inc., was founded on October 13, 2016 in Ontario, Canada. The company operates in Canada, the United States, the United Kingdom and Ireland. The company focuses on developing psychedelics into therapies by designing patented drug discovery platforms, innovative drug delivery systems, novel formulation methods and treatment options for mental health disorders.

Company Financials

EPS

HELP has released its 2026 Q2 earnings. EPS was reported at -1.39, versus the expected 0, missing expectations. The chart below visualizes how HELP has performed over recent quarters, highlighting trends in earnings surprises.